Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2020 | The gut microbiome & triple negative breast cancer

Grazia Vernaci • 14 May 2020
ESMO Breast 2020
Breast Cancer Carboplatin Checkpoint Inhibitors Cyclophosphamide

Grazia Vernaci, MD, University of Padova, Padova, Italy, discusses a trial evaluating the gut microbiome diversity and composition of a population of triple negative breast cancer (TNBC) patients treated with neo-adjuvant chemotherapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Grazia Vernaci

COVID-19 in Italy: managing breast cancer patients
1:04
COVID-19 in Italy: managing breast cancer patients
Grazia Vernaci • 18 May 2020
The importance of BMI as a prognostic factor in breast cancer
0:41
The importance of BMI as a prognostic factor in breast cancer
Grazia Vernaci • 14 May 2020

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals